Protara Therapeutics, Inc. - Common Stock (TARA)

Q4 2020 13F Holders as of 12/31/2020

Type / Class
Equity / Common Stock
Shares outstanding
38.5M
Number of holders
49
Total 13F shares, excl. options
8.78M
Shares change
-420K
Total reported value, excl. options
$212M
Value change
-$5.8M
Number of buys
26
Number of sells
-14
Price
$24.21

Significant Holders of Protara Therapeutics, Inc. - Common Stock (TARA) as of Q4 2020

52 filings reported holding TARA - Protara Therapeutics, Inc. - Common Stock as of Q4 2020.
Protara Therapeutics, Inc. - Common Stock (TARA) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 8.78M shares of 38.5M outstanding shares and own 22.82% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (2.56M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (783K shares), Ikarian Capital, LLC (650K shares), Rock Springs Capital Management LP (643K shares), PERCEPTIVE ADVISORS LLC (609K shares), ORBIMED ADVISORS LLC (450K shares), PRICE T ROWE ASSOCIATES INC /MD/ (434K shares), Artisan Partners Limited Partnership (377K shares), FRANKLIN RESOURCES INC (350K shares), and Cormorant Asset Management, LP (350K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.